Amundi

A material impact from COVID-19

25/03/20 -"We are slashing our EPS going into 2020 and 2021 due to both market effects (net outflows on profitable products as, even if assets might remain in the company, when investors convert risky assets ..."

PDF page sample
Pages
53
Language
English
Published on
25/03/20
Download
You may also be interested by these reports :
12/12/25
Deutsche Börse’s CMD outlined an ambitious 2028 plan targeting 8% organic revenue growth (ex-treasury) and above-62% EBITDA margins via strict cost ...
11/12/25
Since our last teaser, written right after the reverse takeover of Picanol by Tessenderlo (BUY ; Belgium) in early 2023, the performance of the ...
09/12/25
Thyssenkrupp released its FY24/25 results, closing in September. While results aligned with consensus expectations and slightly exceeded cash flow ...
09/12/25
Of note: IDI has been tracked by AlphaValue as part of a sponsored research contract since September 2021. If private equity players were a family, ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO